General Information of the Compound
Compound ID
CP0203512
Compound Name
2-[6-(4-chlorophenyl)thieno[3,2-d]pyrimidin-4-yl]oxyacetic acid
    Show/Hide
Structure
Formula
C14H9ClN2O3S
Molecular Weight
320.757
Canonical SMILES
OC(=O)COc1ncnc2cc(sc12)-c1ccc(Cl)cc1
    Show/Hide
InChI
InChI=1S/C14H9ClN2O3S/c15-9-3-1-8(2-4-9)11-5-10-13(21-11)14(17-7-16-10)20-6-12(18)19/h1-5,7H,6H2,(H,18,19)
    Show/Hide
InChIKey
KGLQMZWSWMDATD-UHFFFAOYSA-N
Physicochemical Property
logP
3.4751
Rotatable Bonds
4
Heavy Atom Count
21
Polar Areas
72.31
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 56672666
ChEMBL ID
CHEMBL1836637
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02503, Serine/threonine-protein kinase 17B
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS